Zoetis Inc. (ZTS) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $5.00M; Additional Paid in CapitalUSD $1.13B; Treasury Stock, ValueUSD $11.85B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-796.00M.
- 2026-03-31: Common Stock, Value, IssuedUSD $5.00M; Additional Paid in CapitalUSD $1.10B; Treasury Stock, ValueUSD $11.29B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-772.00M.
- 2025-12-31: Common Stock, Value, IssuedUSD $5.00M; Additional Paid in CapitalUSD $1.10B; Treasury Stock, ValueUSD $10.69B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-804.00M.
- 2025-12-18: Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD (m); Treasury Stock, ValueUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m).
Zoetis Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock, Shares, Acquired shares | Noncontrolling Interest, Decrease from Deconsolidation USD | Preferred Stock, Value, Outstanding USD | Treasury Stock, Carrying Basis USD | Adjustments to Additional Paid in Capital, Other USD | Noncontrolling Interest, Increase from Sale of Parent Equity Interest USD | Noncontrolling Interest, Increase from Business Combination USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.00M | $1.13B | $11.85B | $-796.00M | $14.65B | $3.15B | $3.15B | 87.74M | 3 month · $558.00M 6 month · $1.17B | 3 month · $26.00M 6 month · $39.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $5.00M | $1.10B | $11.29B | $-772.00M | $14.18B | $3.23B | $3.23B | 81.54M | 3 month · $612.00M | 3 month · $13.00M | 3 month · 12.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $5.00M | $1.10B | $10.69B | $-804.00M | $13.80B | $3.42B | $3.42B | 76.96M | 12 month · $3.25B | 12 month · $73.00M | 12 month · 300.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-18 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 2.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $5.00M | $1.22B | $8.61B | $-818.00M | $13.59B | $5.40B | $5.40B | 60.43M | 3 month · $381.00M 9 month · $1.17B | 3 month · $22.00M 9 month · $50.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $5.00M | $1.20B | $8.23B | $-877.00M | $12.87B | $4.98B | $5.16B | 57.95M | 3 month · $341.00M 6 month · $788.00M | 3 month · $26.00M 6 month · $28.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $5.00M | $1.18B | $7.89B | $-1.02B | $12.38B | $4.66B | $4.87B | 55.85M | 3 month · $447.00M | 3 month · $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $5.00M | $1.18B | $7.45B | $-940.00M | $11.97B | $4.77B | $4.84B | 53.42M | 12 month · $1.86B | 12 month · $65.00M | 12 month · 600.00K | 12 month · $4.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $5.00M | $1.16B | $6.89B | $-851.00M | $11.81B | $5.23B | $5.23B | 50.34M | 3 month · $427.00M 9 month · $1.31B | 3 month · $19.00M 9 month · $45.00M | (m) | 3 month · $4.00M 9 month · $4.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $5.00M | $1.15B | $6.46B | $-845.00M | $11.12B | $4.97B | $4.96B | 48.08M | 3 month · $538.00M 6 month · $880.00M | 3 month · $22.00M 6 month · $26.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $5.00M | $1.13B | $5.93B | $-841.00M | $10.70B | $5.06B | $5.05B | 44.94M | 3 month · $342.00M | 3 month · $4.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $5.00M | $1.13B | $5.60B | $-839.00M | $10.29B | $5.00B | $4.99B | 43.50M | 12 month · $1.10B | 12 month · $88.00M | 12 month · 900.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $5.00M | $1.12B | $5.37B | $-814.00M | $10.14B | $5.08B | $5.07B | 42.37M | 3 month · $252.00M 9 month · $864.00M | 3 month · $28.00M 9 month · $61.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $5.00M | $1.10B | $5.13B | $-895.00M | $9.54B | $4.62B | $4.62B | 41.14M | 3 month · $327.00M 6 month · $612.00M | 3 month · $26.00M 6 month · $33.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $5.00M | $1.08B | $4.81B | $-828.00M | $9.04B | $4.49B | $4.49B | (m) | 3 month · $285.00M | 3 month · $7.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 39.40M |
| 2022-12-31 | $5.00M | $1.09B | $4.54B | $-817.00M | $8.67B | $4.41B | $4.40B | 38.10M | 12 month · $1.59B | 12 month · $23.00M | 12 month · 700.00K | (m) | (m) | (m) | (m) | (m) | (m) | 38.08M |
| 2022-09-30 | $5.00M | $1.07B | $4.14B | $-809.00M | $8.53B | $4.66B | $4.66B | (m) | 3 month · $377.00M 9 month · $1.19B | 3 month · $17.00M 9 month · $5.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 35.45M |
| 2022-06-30 | $5.00M | $1.06B | $3.77B | $-722.00M | $8.00B | $4.58B | $4.58B | (m) | 3 month · $451.00M 6 month · $812.00M | 3 month · $15.00M 6 month · $-12.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 33.28M |
| 2022-03-31 | $5.00M | $1.05B | $3.32B | $-704.00M | $7.63B | $4.66B | $4.66B | (m) | 3 month · $361.00M | 3 month · $-27.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 30.68M |
| 2021-12-31 | $5.00M | $1.07B | $2.95B | $-764.00M | $7.19B | $4.54B | $4.54B | 29.30M | 12 month · $743.00M | 12 month · $20.00M | 12 month · 1.30M | (m) | (m) | (m) | (m) | (m) | (m) | 29.32M |
| 2021-09-30 | $5.00M | $1.06B | $2.76B | $-667.00M | $7.04B | $4.68B | $4.68B | (m) | 3 month · $198.00M 9 month · $545.00M | 3 month · $18.00M 9 month · $5.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 28.52M |
| 2021-06-30 | $5.00M | $1.04B | $2.57B | $-623.00M | $6.49B | $4.35B | $4.35B | (m) | 3 month · $166.00M 6 month · $347.00M | 3 month · $24.00M 6 month · $-13.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 27.68M |
| 2021-03-31 | $5.00M | $1.03B | $2.41B | $-633.00M | $6.10B | $4.09B | $4.09B | (m) | 3 month · $181.00M | 3 month · $-37.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 26.92M |
| 2020-12-31 | $5.00M | $1.06B | $2.23B | $-730.00M | $5.66B | $3.77B | $3.77B | 26.60M | 12 month · $250.00M | 12 month · $78.00M | 12 month · 1.60M | (m) | (m) | (m) | (m) | (m) | (m) | 26.60M |
| 2020-09-30 | $5.00M | $1.04B | $2.23B | $-735.00M | $5.53B | $3.60B | $3.61B | (m) | 9 month · $250.00M | 3 month · $19.00M 9 month · $62.00M | (m) | (m) | (m) | (m) | (m) | 9 month · $6.00M | (m) | 26.65M |
| 2020-06-30 | $5.00M | $1.03B | $2.25B | $-856.00M | $5.05B | $2.98B | $2.99B | (m) | 6 month · $250.00M | 3 month · $22.00M 6 month · $43.00M | (m) | (m) | (m) | (m) | (m) | 3 month · $6.00M 6 month · $6.00M | (m) | 26.89M |
| 2020-03-31 | $5.00M | $1.02B | $2.25B | $-781.00M | $4.76B | (m) | $2.75B | (m) | 3 month · $250.00M | 3 month · $21.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 27.00M |
| 2019-12-31 | $5.00M | $1.04B | $2.04B | $-726.00M | $4.43B | $2.71B | $2.71B | (m) | 12 month · $626.00M | 12 month · $73.00M | 12 month · 1.80M | (m) | (m) | (m) | (m) | (m) | (m) | 26.40M |
| 2019-09-30 | $5.00M | $1.03B | $1.88B | $-699.00M | $4.22B | (m) | $2.68B | (m) | 3 month · $150.00M 9 month · $450.00M | 3 month · $13.00M 9 month · $52.00M | 9 month · 4.40M | (m) | $0.00 | (m) | (m) | (m) | (m) | 25.10M |
| 2019-06-30 | $5.00M | $1.02B | $1.73B | $-669.00M | $3.79B | (m) | $2.41B | (m) | 3 month · $150.00M 6 month · $300.00M | 3 month · $22.00M 6 month · $39.00M | 3 month · 1.44M 6 month · 3.10M | (m) | $0.00 | (m) | (m) | (m) | (m) | 24.10M |
| 2019-03-31 | $5.00M | $1.01B | $1.59B | $-598.00M | $3.50B | (m) | $2.32B | (m) | 3 month · $150.00M | 3 month · $17.00M | 3 month · 1.70M | (m) | $0.00 | (m) | (m) | (m) | (m) | 22.90M |
| 2018-12-31 | $5.00M | $1.03B | $1.49B | $-629.00M | $3.27B | $2.19B | $2.19B | (m) | 12 month · $698.00M | 12 month · $81.00M | 12 month · 1.70M | (m) | $0.00 | (m) | 12 month · $-14.00M | (m) | (m) | 22.30M |
| 2018-09-30 | $5.00M | $1.01B | $1.34B | $-619.00M | $3.07B | $2.12B | $2.12B | (m) | 3 month · $143.00M 9 month · $548.00M | 3 month · $33.00M 9 month · $61.00M | 9 month · 6.60M | (m) | $0.00 | (m) | 9 month · $-14.00M | (m) | (m) | 20.90M |
| 2018-06-30 | $5.00M | $1.00B | $1.22B | $-543.00M | $2.72B | $1.97B | $1.98B | (m) | 3 month · $215.00M 6 month · $405.00M | 3 month · $16.00M 6 month · $28.00M | 3 month · 2.55M 6 month · 4.95M | (m) | $0.00 | (m) | (m) | (m) | (m) | 19.60M |
| 2018-03-31 | $5.00M | $990.00M | $1.00B | $-429.00M | $2.40B | $1.96B | $1.98B | (m) | 3 month · $190.00M | 3 month · $12.00M | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | 17.17M |
| 2017-12-31 | $5.00M | $1.01B | $852.00M | $-505.00M | $2.11B | $1.77B | $1.79B | (m) | 12 month · $500.00M | 12 month · $68.00M | 12 month · 1.60M | (m) | $0.00 | (m) | (m) | (m) | (m) | 15.80M |
| 2017-10-01 | $5.00M | $1.03B | $733.00M | $-455.00M | $2.14B | $1.99B | $2.02B | (m) | 9 month · $375.00M | 9 month · $52.00M | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | 14.06M |
| 2017-07-02 | $5.00M | $1.02B | $615.00M | $-542.00M | $1.84B | $1.72B | $1.75B | (m) | 6 month · $250.00M | 6 month · $39.00M | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | 12.23M |
| 2017-04-02 | $5.00M | $1.01B | $510.00M | $-552.00M | $1.65B | $1.61B | $1.64B | (m) | 3 month · $125.00M | 3 month · $14.00M | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | 10.56M |
| 2016-12-31 | $5.00M | $1.02B | $421.00M | $-598.00M | $1.48B | $1.49B | $1.50B | (m) | 12 month · $300.00M | 12 month · $64.00M | 12 month · 1.72M | 12 month · $6.00M | $0.00 | (m) | (m) | (m) | (m) | 9.00M |
| 2016-10-02 | $5.00M | $1.01B | $351.00M | $-506.00M | $1.42B | $1.58B | $1.60B | (m) | 9 month · $225.00M | 9 month · $51.00M | (m) | 9 month · $6.00M | $0.00 | (m) | (m) | (m) | (m) | 10.56M |
| 2016-07-03 | $5.00M | $1.01B | $294.00M | $-554.00M | $1.19B | $1.36B | $1.37B | (m) | 6 month · $151.00M | 6 month · $37.00M | (m) | 6 month · $6.00M | $0.00 | (m) | (m) | (m) | (m) | 6.50M |
| 2016-04-03 | $5.00M | $1.01B | $245.00M | $-618.00M | $1.02B | $1.17B | $1.19B | (m) | 3 month · $76.00M | 3 month · $13.00M | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | 5.48M |
| 2015-12-31 | $5.00M | $1.01B | $203.00M | $-622.00M | $876.00M | $1.07B | $1.09B | (m) | 12 month · $199.00M | 12 month · $47.00M | 12 month · 57.27K | (m) | $0.00 | $203.10M | (m) | (m) | (m) | 4.41M |
| 2015-09-27 | $5.00M | $993.00M | $150.00M | $-562.00M | $943.00M | $1.23B | $1.25B | (m) | 9 month · $148.00M | 9 month · $31.00M | (m) | (m) | $0.00 | $150.10M | (m) | (m) | (m) | 3.24M |
| 2015-06-28 | $5.00M | $980.00M | $100.00M | $-504.00M | $795.00M | $1.18B | $1.20B | (m) | 6 month · $98.00M | 6 month · $19.00M | 6 month · 20.00K | (m) | $0.00 | $99.70M | (m) | (m) | (m) | 2.16M |
| 2015-03-29 | $5.00M | $969.00M | $49.00M | $-479.00M | $832.00M | $1.28B | $1.30B | (m) | 3 month · $47.00M | 3 month · $8.00M | 3 month · 20.00K | (m) | $0.00 | $48.80M | (m) | (m) | (m) | 1.09M |
| 2014-12-31 | $5.00M | $958.00M | $0.00 | $-361.00M | $709.00M | $1.31B | $1.34B | (m) | 12 month · $500.00K | 12 month · $31.00M | 12 month · 14.74K | (m) | $0.00 | $500.00K | (m) | (m) | (m) | 14.74K |
| 2014-09-28 | $5.00M | $938.00M | $0.00 | $-240.00M | $661.00M | $1.36B | $1.39B | (m) | 9 month · $400.00K | 9 month · $23.00M | 9 month · 14.00K | (m) | $0.00 | $400.00K | (m) | (m) | (m) | 13.79K |
| 2014-06-29 | $5.00M | $923.00M | $0.00 | $-199.00M | $531.00M | $1.26B | $1.28B | (m) | 6 month · $400.00K | 6 month · $13.00M | 6 month · 13.00K | (m) | $0.00 | $400.00K | (m) | (m) | (m) | 13.42K |
| 2014-03-30 | $5.00M | $906.00M | $0.00 | $-229.00M | $395.00M | $1.08B | $1.10B | (m) | 3 month · $200.00K | 3 month · $5.00M | 3 month · 7.00K | (m) | $0.00 | $200.00K | (m) | (m) | (m) | 6.76K |
| 2013-12-31 | $5.00M | $878.00M | $0.00 | $-219.00M | $276.00M | $940.00M | $962.00M | (m) | (m) | 12 month · $43.00M | (m) | (m) | $0.00 | $0.00 | (m) | (m) | (m) | 0.00 |
| 2013-09-29 | $5.00M | $876.00M | (m) | $-245.00M | $207.00M | $843.00M | $866.00M | (m) | (m) | 9 month · $37.00M | 9 month · 247.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $5.00M | $869.00M | (m) | $-183.00M | $109.00M | $800.00M | $823.00M | (m) | (m) | 6 month · $31.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | $812.00M | (m) | $-121.00M | $13.00M | $709.00M | $724.00M | (m) | (m) | 3 month · $11.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $0.00 | $0.00 | (m) | $-157.00M | $0.00 | $4.03B | $4.04B | (m) | (m) | 12 month · $28.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | $4.11B | (m) | (m) | 9 month · $18.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-07-01 | (m) | (m) | (m) | (m) | (m) | (m) | $3.93B | (m) | (m) | 6 month · $12.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-04-01 | (m) | (m) | (m) | (m) | (m) | (m) | $3.95B | (m) | (m) | 3 month · $6.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | $-65.00M | (m) | (m) | $3.74B | (m) | (m) | 12 month · $19.00M | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $16.00M | (m) |
| 2010-12-31 | (m) | (m) | (m) | $-74.00M | (m) | (m) | $3.34B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |